North America

Thu
18
Jul

4 CBD questions we need researchers to answer ASAP

CBD research hasn’t quite caught up to the compound’s rapid rise in popularity. Experimentation in the lab is just beginning, putting consumers in the awkward position of knowing that the compound produces powerful therapeutic effects that remain shrouded in mystery.

Now that legalization is in full force and CBD is primed to become one of the largest industries in the U.S., it’s the perfect time for researchers to answer some of the most pressing questions about the compound. Here are four of the most popular ones.

Thu
18
Jul

Discover the $35bn North American cannabis market

It was recently reported that the North American cannabis market will reach $35bn by 2023, here Health Europa look at the North American cannabis market.

In 2017, “the North American legal cannabis market reached a value of more than $8bn” (~€7.86 bn). in accordance with this, it has also been argued that “the market is further expected to reach a value of around $35bn by 2023, exhibiting a CAGR [‘Compound Annual Growth Rate’] of 28% during 2018-2023.1 Can the world meet the expectations of the North American cannabis market?

Thu
18
Jul

The CBD industry is betting that pets need to chill, too

Two years ago, Dingo was going to be put down. The 14-year-old basenji, in pain from arthritis in her neck and spine, could barely walk and wouldn’t eat. She suffered from anxiety and had early-stage kidney disease. Then she started taking cannabis.

Kelsey Brown, Dingo’s owner, decided to dose her with drops of CBD, or cannibidiol, three times a day, using a tincture that runs US$120 for a 1-ounce bottle. It was a last-ditch effort to ease the dog’s pain and anxiety before euthanasia became a reality. “Within a week she could actually jump on the couch again,” says Brown, a dog trainer in Mora, Minn.

Thu
18
Jul

Pot stocks to watch as we enter the second half of summer ​

The marijuana stock market has grown drastically over the course of the past few years. In that time, we have seen company values skyrocket. Additionally, we have seen the amount of investor faith in the pot stock space grow as well. All of this has led to one of the friendliest investor spaces we have seen in recent times.

Thu
18
Jul

What a good website can do for your dispensary

At such an early stage in the growth process, the cannabis industry is unlike any other industry in the world right now, especially in the retail/dispensary sector.  But while cannabis is extremely unique in its own way, it still carries a number of similarities to established industries and businesses that operate in more traditional retail capacities.  Those similarities offer glimpses into the likely future of the cannabis industry, giving us learning opportunities from businesses that have already experienced changes and progressions that literally change everything about how their industry operates.

Thu
18
Jul

Worried about the bee population? A study says hemp can help

Populations are in decline and the worst honeybee hive loss on record happened last winter. Beekeepers reported to the U.S. Department of Agriculture a 40% loss of their colonies over the past year. The cause: debilitating challenges, due to a number of different stressors, but chief among them is the overall health of respective habitats.

Wed
17
Jul

Cannabis CEOs are white men, just like in the rest of the corporate world

Bloomberg Businessweek — When Nancy Whiteman, 61, founded her marijuana edibles company, Wana Brands, almost a decade ago in Boulder, Colo., the legal industry was relatively diverse and dominated by local startups. It helped that Wall Street banks and institutional investors took a hands-off approach to cannabis, leery of getting involved with a drug that’s still banned by the federal government. “It was a pretty even playing field for everybody—men, women, anybody who was interested,” Whiteman says.

Wed
17
Jul

Ex-CannTrust president fears for firm's future amid regulatory probe

Health Canada changed the way it conducted cannabis industry inspections last year amid an “insatiable appetite” for licences, according to one of CannTrust Holdings Inc.’s former top executives, in a move that potentially opened the door for the regulatory fiasco that has thrust the pot producer into the spotlight.

Brad Rogers, the former president of CannTrust who worked at the Vaughan, Ont.-based company from April 2016 to last October, told BNN Bloomberg that he observed a streamlining for licence submissions after Health Canada was flooded with applications before Canada legalized recreational cannabis in October.

Wed
17
Jul

Cannabis stocks rally after FDA says it will speed up effort to create rules for CBD

Cannabis stocks were mostly higher on Monday, after the U.S. Food and Drug Administration said it is expediting its effort to create a regulatory framework for CBD with plans to publish a report on its progress by early fall.

Amy Abernathy, acting chief information officer, said in a series of tweets sent on Friday that the agency is “expediting its work to address the many questions about cannabidiol. This is an important national issue with public health impact, and an important topic for American hemp farmers and many other stakeholders.”

Wed
17
Jul

The marijuana industry needs innovation to thrive

There’s a kind of boom and bust cycle that tends to follow the development of every new technology, or every major societal change. People get excited about the possibilities of the shiny new concept, they dump money into stocks, they start businesses in the industry, and they push public enthusiasm even higher. Then, at some point, someone realizes all these businesses aren’t really innovating or providing the value people thought they had, and the bubble bursts.

Pages

Subscribe to RSS - North America